Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
MAPKAPK-2 (S328) polyclonal antibody BS1808
  • Western blot (WB) analysis of MAPKAPK-2 (S328) polyclonal antibody at 1:500 dilution Lane1:C6 whole cell lysate(40ug) Lane2:The Brain tissue lysate of Rat(40ug) Lane3:The Brain tissue lysate of Mouse(40ug) Lane4:HEK293T whole cell lysate(40ug)
  • Immunohistochemistry (IHC) analyzes of MAPKAPK-2 (S328) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Product NameMAPKAPK-2 (S328) polyclonal antibody
Catalog No.BS1808
Swiss-ProtP49137
Host Rabbit
ReactivityHuman,Mouse,Rat
ApplicationsWB IHC
Application_allWB: 1:500~1:1000 IHC: 1:50~1:200
BiowMW~ 46 kDa
Alternative NameMAPKAP Kinase 2; MAPK-activated protein kinase 2; MAPKAP kinase 2; MAPKAPK-2; MK2; EC 2.7.11.1; MAPKAPK2
Purification&PurityThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $158
100ul $275
Add to cart My orders
Product Name :
MAPKAPK-2 (S328) polyclonal antibody
Background :
MAP kinase activated protein kinase 2 (MAPKAP Kinase 2), also known as p45 hsp27 kinase, is a 45-54 kDa serine/threonine protein kinase that contains a proline rich sequence and two putative SH3 binding sites. MAPKAP Kinase 2 is activated in response to stress, IL1 and TNF, possibly catalyzed by p38/Hog dependent phosphorylation. One of the major substrates of MAPKAP Kinase 2 is hsp27, which stimulates actin polymerization in order to facilitate recovery from destruction of cytoskeleton during cellular stresses. MAPKAP2 is implicated in several disorders including ischemic brain injury and heart failure and has been shown to be important in regulating stress resistance and the production of TNF alpha.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
MAPKAPK-2 (S328) polyclonal antibody detects endogenous levels of MAPKAPK-2 protein.
Immunogen :
Synthetic peptide, corresponding to amino acids 300-350 of Human MAPKAPK-2.
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot (WB) analysis of MAPKAPK-2 (S328) polyclonal antibody at 1:500 dilution Lane1:C6 whole cell lysate(40ug) Lane2:The Brain tissue lysate of Rat(40ug) Lane3:The Brain tissue lysate of Mouse(40ug) Lane4:HEK293T whole cell lysate(40ug)
  • Immunohistochemistry (IHC) analyzes of MAPKAPK-2 (S328) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER